BLPH logo

Bellerophon Therapeutics (BLPH) Return On Assets

Annual ROA

-249.92%
-183.85%-278.27%

December 31, 2022


Summary


Performance

BLPH ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherBLPHprofitabilitymetrics:

Quarterly ROA

-92.24%
+11.63%+11.20%

September 30, 2023


Summary


Performance

BLPH Quarterly ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherBLPHprofitabilitymetrics:

ROA Formula

ROA =  Net Income
Total Assets
✕ 100%

BLPH ROA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-278.3%+4.6%
3 y3 years-146.9%+4.6%
5 y5 years-67.8%-42.4%

BLPH ROA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year+278.3%at low+78.5%+43.3%
5 y5-year+407.8%at low+93.9%+43.3%
alltimeall time-1730.3%+582.3%-481.0%+1337.2%

Bellerophon Therapeutics ROA History

DateAnnualQuarterly
Sep 2023
-
-92.24%(-11.2%)
Jun 2023
-
-103.87%(+23.9%)
Mar 2023
-
-83.84%(-36.6%)
Dec 2022
-249.92%(+278.3%)
-132.17%(+36.7%)
Sep 2022
-
-96.69%(+26.6%)
Jun 2022
-
-76.39%(+24.6%)
Mar 2022
-
-61.31%(+18.7%)
Dec 2021
-66.07%(+34.2%)
-51.67%(-3.3%)
Sep 2021
-
-53.45%(+0.6%)
Jun 2021
-
-53.15%(+11.8%)
Mar 2021
-
-47.56%(-12.7%)
Dec 2020
-49.22%(-51.4%)
-54.49%(-5.4%)
Sep 2020
-
-57.63%(-12.7%)
Jun 2020
-
-66.02%(-41.5%)
Mar 2020
-
-112.76%(+59.6%)
Dec 2019
-101.21%(-760.2%)
-70.67%(+40.6%)
Sep 2019
-
-50.28%(-307.7%)
Jun 2019
-
24.21%(-381.5%)
Mar 2019
-
-8.60%(-182.3%)
Dec 2018
15.33%
10.45%(-116.1%)
DateAnnualQuarterly
Sep 2018
-
-64.79%(-40.6%)
Jun 2018
-
-109.13%(+17.4%)
Mar 2018
-
-92.93%(-46.7%)
Dec 2017
-148.92%(+85.7%)
-174.31%(+35.8%)
Sep 2017
-
-128.34%(-7.0%)
Jun 2017
-
-137.93%(+0.4%)
Mar 2017
-
-137.38%(+58.6%)
Dec 2016
-80.18%(-33.7%)
-86.61%(-5.6%)
Sep 2016
-
-91.72%(-2.6%)
Jun 2016
-
-94.20%(+5.1%)
Mar 2016
-
-89.67%(+8.6%)
Dec 2015
-120.96%(-32.3%)
-82.55%(-6.2%)
Sep 2015
-
-87.96%(-8.5%)
Jun 2015
-
-96.08%(-13.3%)
Mar 2015
-
-110.82%(-23.8%)
Dec 2014
-178.71%(-89.5%)
-145.50%(-40.3%)
Sep 2014
-
-243.66%(-81.6%)
Jun 2014
-
-1325.63%(+54.1%)
Mar 2014
-
-860.42%(+86.5%)
Dec 2013
-1705.12%(+23.5%)
-461.36%
Dec 2012
-1380.32%
-

FAQ

  • What is Bellerophon Therapeutics annual return on assets?
  • What is the all time high annual ROA for Bellerophon Therapeutics?
  • What is Bellerophon Therapeutics annual ROA year-on-year change?
  • What is Bellerophon Therapeutics quarterly return on assets?
  • What is the all time high quarterly ROA for Bellerophon Therapeutics?
  • What is Bellerophon Therapeutics quarterly ROA year-on-year change?

What is Bellerophon Therapeutics annual return on assets?

The current annual ROA of BLPH is -249.92%

What is the all time high annual ROA for Bellerophon Therapeutics?

Bellerophon Therapeutics all-time high annual return on assets is 15.33%

What is Bellerophon Therapeutics annual ROA year-on-year change?

Over the past year, BLPH annual return on assets has changed by -183.85% (-278.27%)

What is Bellerophon Therapeutics quarterly return on assets?

The current quarterly ROA of BLPH is -92.24%

What is the all time high quarterly ROA for Bellerophon Therapeutics?

Bellerophon Therapeutics all-time high quarterly return on assets is 24.21%

What is Bellerophon Therapeutics quarterly ROA year-on-year change?

Over the past year, BLPH quarterly return on assets has changed by +4.45% (+4.60%)